Wilson disease: Pathogenesis and clinical considerations in diagnosis and treatment

Seminars in Liver Disease

Volumn 31, Issue 3, 2011, Pages 245-259

  Rosencrantz, Richard ^a,b   Schilsky, Michael ^b  

^a Department of Pediatrics ^*  (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

ATP7B; ceruloplasmin; copper; Kayser Fleischer rings; Wilson disease

Indexed keywords

ALPHA TOCOPHEROL; AMINOTRANSFERASE; AMYLASE; BILIRUBIN; CERULOPLASMIN; COPPER; CREATINE KINASE; DIMERCAPROL; PENICILLAMINE; SERUM ALBUMIN; TETRATHIOMOLYBDIC ACID; TRIACYLGLYCEROL LIPASE; TRIENTINE; WILSON DISEASE PROTEIN; ZINC;

ACUTE LIVER FAILURE; ADJUVANT THERAPY; AGE; ALBUMIN BLOOD LEVEL; AMINO ACID SUBSTITUTION; AMINOACIDURIA; AMINOTRANSFERASE BLOOD LEVEL; AMYLASE BLOOD LEVEL; ANEMIA; ARTHRITIS; ARTICLE; BEHAVIOR DISORDER; BLEEDING TENDENCY; BONE MARROW SUPPRESSION; BRAIN EDEMA; CATARACT; CAUCASIAN; CHINESE; CHROMOSOME 13; COLITIS; COMPUTER ASSISTED TOMOGRAPHY; CREATINE KINASE BLOOD LEVEL; DIFFERENTIAL DIAGNOSIS; DISEASE MARKER; DRUG ERUPTION; DYSTHYMIA; DYSTONIA; EUROPE; EXON; FAMILY COUNSELING; FAMILY HISTORY; FEVER; FLUID RETENTION; GASTROINTESTINAL SYMPTOM; GENE DELETION; GENE MUTATION; GENETIC SCREENING; GYNECOMASTIA; HEPATIC ENCEPHALOPATHY; HEPATOGRAPHY; HEPATOMEGALY; HEREDITY; HOMEOSTASIS; HUMAN; HYPERBILIRUBINEMIA; HYPOPARATHYROIDISM; HYPOURICEMIA; INCIDENCE; INDIAN; INFERTILITY; INTERNATIONAL NORMALIZED RATIO; JAUNDICE; KAYSER FLEISCHER RING; KIDNEY FAILURE; LABORATORY TEST; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER DISEASE; LIVER FIBROSIS; LIVER HISTOLOGY; LIVER TRANSPLANTATION; LUPUS LIKE SYNDROME; MAINTENANCE THERAPY; MAJOR DEPRESSION; MEDICAL HISTORY; MENTAL INSTABILITY; MOOD DISORDER; MUSCLE RIGIDITY; MYOSITIS; NEPHROLITHIASIS; NEPHROTIC SYNDROME; NEUROIMAGING; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; OSTEOPENIA; PARKINSONISM; PATHOGENESIS; PHYSICAL EXAMINATION; POINT MUTATION; POLAND; PORTAL HYPERTENSION; PREGNANCY; PRIORITY JOURNAL; PROGNOSIS; PSYCHOSOCIAL WITHDRAWAL; SAUDI ARABIA; SCORING SYSTEM; SEX DIFFERENCE; SIDE EFFECT; SIDEROBLASTIC ANEMIA; SPONTANEOUS ABORTION; TREMOR; TRIACYLGLYCEROL LIPASE BLOOD LEVEL; URINALYSIS; WILSON DISEASE;

ADENOSINE TRIPHOSPHATASES; ANTIOXIDANTS; CATION TRANSPORT PROTEINS; CENTRAL NERVOUS SYSTEM DISEASES; CHELATING AGENTS; COPPER; HEPATOLENTICULAR DEGENERATION; HUMANS; PROGNOSIS;

EID: 80052691380     PISSN: 02728087     EISSN: 10988971     Source Type: Journal    
DOI: 10.1055/s-0031-1286056     Document Type: Article

References (98)

1. Wilson S AK. Progressive lenticular degeneration: familial nervous disease associated with cirrhosis of liver. Brain 1912 34 295-509
2. Westphal C. Ueber eine dem bilde der cerebrospinalen grauen degeneration. Arch Psychiatr Nervenkr 1883 14 87-134
3. Gowers W R. Tetanoid chorea associated with cirrhosis of the liver. In: A Manual of Diseases of the Nervous System. London J & A Churchill 1888
4. Pliny the Elder. Natural History A.D. 77. Cambridge, MA/London Harvard University Press/William Heinemann 194954 Book 34
5. Glazebrook A J. Wilson's disease. Edinburgh Med J 1945 52 83-87
6. Cumings J N. The copper and iron content of brain and liver in the normal and in hepato-lenticular degeneration. Brain 1948 71 Pt. 4 410-415
7. Hall H C. La degenerescence hepato-lenticulaire Maladie de Wilson. Pseudo-sclerose. Paris Masson et Cie 1921
8. Bearn A G. Genetic and biochemical aspects of Wilson's disease. Am J Med 1953 15 4 442-449
9. Frydman M, Bonné-Tamir B, Farrer L A. et al. Assignment of the gene for Wilson disease to chromosome 13: linkage to the esterase D locus. Proc Natl Acad Sci U S A 1985 82 6 1819-1821
10. Bull P C., Thomas G R., Rommens J M., Forbes J R., Cox D W. The Wilson disease gene is a putative copper transporting P-type ATPase similar to the Menkes gene. Nat Genet 1993 5 4 327-337 (Pubitemid 23351302)
11. Petrukhin K, Fischer S G., Pirastu M et al. Mapping, cloning and genetic characterization of the region containing the Wilson disease gene. Nat Genet 1993 5 4 338-343 (Pubitemid 23351303)
12. Menghini G, Carnevali O, Orlandi F, Benda N. [Clinical evaluation of liver biopsy: considerations on four year experiences]. Progr Med (Napoli) 1953 9 1 1-10
13. Scheinberg I H., Gitlin D. Deficiency of ceruloplasmin in patients with hepatolenticular degeneration (Wilson's disease). Science 1952 116 3018 484-485
14. Denny-Brown D, Porter H. The effect of BAL (2,3-dimercaptopropanol) on hepatolenticular degeneration (Wilson's disease). N Engl J Med 1951 245 24 917-925
15. Walshe J M. Penicillamine, a new oral therapy for Wilson's disease. Am J Med 1956 21 4 487-495
16. Walshe J M. Treatment of Wilson's disease with trientine (triethylene tetramine) dihydrochloride. Lancet 1982 1 8273 643-647 (Pubitemid 12179933)
17. Gibbs K, Walshe J M. Liver copper concentration in Wilson's disease: effect of treatment with anti-copper agents. J Gastroenterol Hepatol 1990 5 4 420-424 (Pubitemid 20254145)
18. Brewer G J., Dick R D., Yuzbasiyan-Gurkin V, Tankanow R, Young A B., Kluin K J. Initial therapy of patients with Wilson's disease with tetrathiomolybdate. Arch Neurol 1991 48 1 42-47
19. Schouwink G. Dehepatocerebrale degeneratie, met een onderzoek naar de koperstofwisseling [MD thesis]. Amsterdam University of Amsterdam 1961
20. Sternlieb I, Scheinberg I H. Prevention of Wilson's disease in asymptomatic patients. N Engl J Med 1968 278 7 352-359
21. Tapiero H, Townsend D M., Tew K D. Trace elements in human physiology and pathology. Copper. Biomed Pharmacother 2003 57 9 386-398 (Pubitemid 37494714)
22. Linder M C. The Biochemistry of Copper. New York Plenum 1991
23. Linder M C., Hazegh-Azam M. Copper biochemistry and molecular biology. Am J Clin Nutr 1996 63 5 797S-811S (Pubitemid 26126602)
24. Valko M, Morris H, Cronin M T. Metals, toxicity and oxidative stress. Curr Med Chem 2005 12 10 1161-1208 (Pubitemid 40655271)
25. Mufti A R., Burstein E, Csomos R A. et al. XIAP Is a copper binding protein deregulated in Wilson's disease and other copper toxicosis disorders. Mol Cell 2006 21 6 775-785 (Pubitemid 43376128)
26. Edwards C Q., Williams D M., Cartwright G E. Hereditary hypoceruloplasminemia. Clin Genet 1979 15 4 311-316 (Pubitemid 9181124)
27. Nittis T, Gitlin J D. The copper-iron connection: hereditary aceruloplasminemia. Semin Hematol 2002 39 4 282-289
28. Morita H, Ikeda S, Yamamoto K et al. Hereditary ceruloplasmin deficiency with hemosiderosis: a clinicopathological study of a Japanese family. Ann Neurol 1995 37 5 646-656
29. Human Gene Mutation Database (Cardiff). Available at: http://www.hgmd.cf.ac.uk/ac/index.php Accessed June 6, 2011
30. Wilson's Disease Mutation Database. Available at: http://www. wilsondisease.med.ualberta.ca/index.asp Accessed June 6, 2011
31. Ferenci P. Regional distribution of mutations of the ATP7B gene in patients with Wilson disease: impact on genetic testing. Hum Genet 2006 120 2 151-159 (Pubitemid 44204003)
32. Vrabelova S, Letocha O, Borsky M, Kozak L. Mutation analysis of the ATP7B gene and genotype/phenotype correlation in 227 patients with Wilson disease. Mol Genet Metab 2005 86 1-2 277-285 (Pubitemid 41412185)
33. Wu Z Y., Wang N, Lin M T., Fang L, Murong S X., Yu L. Mutation analysis and the correlation between genotype and phenotype of Arg778Leu mutation in chinese patients with Wilson disease. Arch Neurol 2001 58 6 971-976 (Pubitemid 32537472)
34. Kumar S, Thapa B R., Kaur G, Prasad R. Familial gene analysis for Wilson disease from north-west Indian patients. Ann Hum Biol 2006 33 2 177-186
35. Al Jumah M, Majumdar R, Al Rajeh S et al. A clinical and genetic study of 56 Saudi Wilson disease patients: identification of Saudi-specific mutations. Eur J Neurol 2004 11 2 121-124 (Pubitemid 38230788)
36. Bennett J, Hahn S. Clinical molecular diagnosis of Wilson disease. Semin Liver Dis 2011 31 3 233-238
37. Ala A, Schilsky M. Genetic modifiers of liver injury in hereditary liver disease. Semin Liver Dis 2011 31 2 208-214
38. Stuehler B, Reichert J, Stremmel W, Schaefer M. Analysis of the human homologue of the canine copper toxicosis gene MURR1 in Wilson disease patients. J Mol Med 2004 82 9 629-634 (Pubitemid 39312668)
39. Markiewicz-Kijewska M, Szymczak M, Ismail H et al. Liver transplantation for fulminant Wilson's disease in children. Ann Transplant 2008 13 2 28-31
40. Saito T. Presenting symptoms and natural history of Wilson disease. Eur J Pediatr 1987 146 3 261-265 (Pubitemid 17066922)
41. Giagheddu A, Demelia L, Puggioni G et al. Epidemiologic study of hepatolenticular degeneration (Wilson's disease) in Sardinia (1902-1983). Acta Neurol Scand 1985 72 1 43-55 (Pubitemid 16240683)
42. Stremmel W, Meyerrose K W., Niederau C, Hefter H, Kreuzpaintner G, Strohmeyer G. Wilson disease: clinical presentation, treatment, and survival. Ann Intern Med 1991 115 9 720-726
43. Oder W, Grimm G, Kollegger H, Ferenci P, Schneider B, Deecke L. Neurological and neuropsychiatric spectrum of Wilson's disease: a prospective study of 45 cases. J Neurol 1991 238 5 281-287
44. Park R H., McCabe P, Fell G S., Russell R I. Wilson's disease in Scotland. Gut 1991 32 12 1541-1545
45. Schiefermeier M, Kollegger H, Madl C et al. The impact of apolipoprotein E genotypes on age at onset of symptoms and phenotypic expression in Wilson's disease. Brain 2000 123 Pt 3 585-590 (Pubitemid 30099542)
46. Wilson D C., Phillips M J., Cox D W., Roberts E A. Severe hepatic Wilson's disease in preschool-aged children. J Pediatr 2000 137 5 719-722
47. Ala A, Borjigin J, Rochwarger A, Schilsky M. Wilson disease in septuagenarian siblings: Raising the bar for diagnosis. Hepatology 2005 41 3 668-670 (Pubitemid 40289516)
48. Perri R E., Hahn S H., Ferber M J., Kamath P S. Wilson diseasekeeping the bar for diagnosis raised. Hepatology 2005 42 4 974 (Pubitemid 41401137)
49. Schilsky M L., Scheinberg I H., Sternlieb I. Prognosis of Wilsonian chronic active hepatitis. Gastroenterology 1991 100 3 762-767
50. Eisenbach C, Sieg O, Stremmel W, Encke J, Merle U. Diagnostic criteria for acute liver failure due to Wilson disease. World J Gastroenterol 2007 13 11 1711-1714 (Pubitemid 46711343)
51. Dabrowska E, Jaboska-Kaszewska I, Oziebowski A, Falkiewicz B. Acute haemolytic syndrome and liver failure as the first manifestations of Wilson's disease. Med Sci Monit 2001 7 Suppl 1 246-251
52. Ferenci P, Caca K, Loudianos G et al. Diagnosis and phenotypic classification of Wilson disease. Liver Int 2003 23 3 139-142 (Pubitemid 37265785)
53. Wong R J., Gish R, Schilsky M, Frenette C. A clinical assessment of Wilson disease in patients with concurrent liver disease. J Clin Gastroenterol 2011 45 3 267-273
54. Bhattacharya K, Velickovic M, Schilsky M, Kaufmann H. Autonomic cardiovascular reflexes in Wilson's disease. Clin Auton Res 2002 12 3 190-192 (Pubitemid 34994580)
55. Meenakshi-Sundaram S, Taly A B., Kamath V, Arunodaya G R., Rao S, Swamy H S. Autonomic dysfunction in Wilson's diseasea clinical and electrophysiological study. Clin Auton Res 2002 12 3 185-189 (Pubitemid 34994579)
56. Akil M, Brewer G J. Psychiatric and behavioral abnormalities in Wilson's disease. Adv Neurol 1995 65 171-178
57. Shanmugiah A, Sinha S, Taly A B. et al. Psychiatric manifestations in Wilson's disease: a cross-sectional analysis. J Neuropsychiatry Clin Neurosci 2008 20 1 81-85 (Pubitemid 351295032)
58. Roberts E A., Schilsky M L., American Association for Study of Liver Diseases (AASLD). Diagnosis and treatment of Wilson disease: an update. Hepatology 2008 47 6 2089-2111 (Pubitemid 351945575)
59. Sternlieb I. Wilson's disease. Clin Liver Dis 2000 4 1 229-239 viii-ix (Pubitemid 33041495)
60. Steindl P, Ferenci P, Dienes H P. et al. Wilson's disease in patients presenting with liver disease: a diagnostic challenge. Gastroenterology 1997 113 1 212-218 (Pubitemid 27281776)
61. Nicastro E, Ranucci G, Vajro P, Vegnente A, Iorio R. Re-evaluation of the diagnostic criteria for Wilson disease in children with mild liver disease. Hepatology 2010 52 6 1948-1956
62. Fleming C R., Dickson E R., Wahner H W., Hollenhorst R W., McCall J T. Pigmented corneal rings in non-Wilsonian liver disease. Ann Intern Med 1977 86 3 285-288 (Pubitemid 8055504)
63. Frommer D, Morris J, Sherlock S, Abrams J, Newman S. Kayser-Fleischer- like rings in patients without Wilson's disease. Gastroenterology 1977 72 6 1331-1335 (Pubitemid 8116710)
64. Korman J D., Volenberg I, Balko J et al, Pediatric and Adult Acute Liver Failure Study Groups. Screening for Wilson disease in acute liver failure: a comparison of currently available diagnostic tests. Hepatology 2008 48 4 1167-1174
65. Sternlieb I, Feldmann G. Effects of anticopper therapy on hepatocellular mitochondria in patients with Wilson's disease: an ultrastructural and stereological study. Gastroenterology 1976 71 3 457-461
66. Ferenci P, Steindl-Munda P, Vogel W et al. Diagnostic value of quantitative hepatic copper determination in patients with Wilson's disease. Clin Gastroenterol Hepatol 2005 3 8 811-818 (Pubitemid 41116735)
67. Aisen A M., Martel W, Gabrielsen T O. et al. Wilson disease of the brain: MR imaging. Radiology 1985 157 1 137-141 (Pubitemid 16215157)
68. Shaver W A., Bhatt H, Combes B. Low serum alkaline phosphatase activity in Wilson's disease. Hepatology 1986 6 5 859-863 (Pubitemid 16006738)
69. Manolaki N, Nikolopoulou G, Daikos G L. et al. Wilson disease in children: analysis of 57 cases. J Pediatr Gastroenterol Nutr 2009 48 1 72-77
70. Walia B NS, Singh S, Marwaha R K., Bhusnurmath S R., Dilawari J B. Fulminant hepatic failure and acute intravascular haemolysis as presenting manifestations of Wilson's disease in young children. J Gastroenterol Hepatol 1992 7 4 370-373
71. Askari F K., Greenson J, Dick R D., Johnson V D., Brewer G J. Treatment of Wilson's disease with zinc. XVIII. Initial treatment of the hepatic decompensation presentation with trientine and zinc. J Lab Clin Med 2003 142 6 385-390 (Pubitemid 38102022)
72. Merle U, Schaefer M, Ferenci P, Stremmel W. Clinical presentation, diagnosis and long-term outcome of Wilson's disease: a cohort study. Gut 2007 56 1 115-120 (Pubitemid 46044897)
73. Jhang J S., Schilsky M L., Lefkowitch J H., Schwartz J. Therapeutic plasmapheresis as a bridge to liver transplantation in fulminant Wilson disease. J Clin Apher 2007 22 1 10-14 (Pubitemid 46407054)
74. Asfaha S, Almansori M, Qarni U, Gutfreund K S. Plasmapheresis for hemolytic crisis and impending acute liver failure in Wilson disease. J Clin Apher 2007 22 5 295-298 (Pubitemid 350013066)
75. Chiu A, Tsoi N S., Fan S T. Use of the molecular adsorbents recirculating system as a treatment for acute decompensated Wilson disease. Liver Transpl 2008 14 10 1512-1516
76. Sen S, Felldin M, Steiner C et al. Albumin dialysis and molecular adsorbents recirculating system (MARS) for acute Wilson's disease. Liver Transpl 2002 8 10 962-967 (Pubitemid 35154030)
77. Dhawan A, Taylor R M., Cheeseman P, De Silva P, Katsiyiannakis L, Mieli-Vergani G. Wilson's disease in children: 37-year experience and revised King's score for liver transplantation. Liver Transpl 2005 11 4 441-448 (Pubitemid 40533213)
78. Walshe J M. Pregnancy in Wilson's disease. Q J Med 1977 46 181 73-83 (Pubitemid 8041050)
79. Walshe J M. The management of pregnancy in Wilson's disease treated with trientine. Q J Med 1986 58 225 81-87 (Pubitemid 16101944)
80. Brewer G J., Dick R D., Johnson V D., Fink J K., Kluin K J., Daniels S. Treatment of Wilson's disease with zinc XVI: treatment during the pediatric years. J Lab Clin Med 2001 137 3 191-198 (Pubitemid 32203199)
81. Schumacher G, Platz K P., Mueller A R. et al. Liver transplantation in neurologic Wilson's disease. Transplant Proc 2001 33 1-2 1518-1519 (Pubitemid 32237956)
82. Medici V, Trevisan C P., D'Incà R et al. Diagnosis and management of Wilson's disease: results of a single center experience. J Clin Gastroenterol 2006 40 10 936-941 (Pubitemid 44690770)
83. Schumacher G, Mueller A R., Platz K P. et al. Neurologic symptoms improve in patients with Wilson's disease despite immunosuppression. Transplant Proc 1996 28 6 3099-3100 (Pubitemid 26415409)
84. Rodo M, Czonkowska A, Pulawska M, Swiderska M, Tarnacka B, Wehr H. The level of serum lipids, vitamin E and low density lipoprotein oxidation in Wilson's disease patients. Eur J Neurol 2000 7 5 491-494 (Pubitemid 32530108)
85. von Herbay A, de Groot H, Hegi U, Stremmel W, Strohmeyer G, Sies H. Low vitamin E content in plasma of patients with alcoholic liver disease, hemochromatosis and Wilson's disease. J Hepatol 1994 20 1 41-46 (Pubitemid 24043084)
86. Sokol R J., McKim J M. Jr, Devereaux M W. Alpha-tocopherol ameliorates oxidant injury in isolated copper-overloaded rat hepatocytes. Pediatr Res 1996 39 2 259-263 (Pubitemid 26045060)
87. van den Berghe P VE, Stapelbroek J M., Krieger E et al. Reduced expression of ATP7B affected by Wilson disease-causing mutations is rescued by pharmacological folding chaperones 4-phenylbutyrate and curcumin. Hepatology 2009 50 6 1783-1795
88. Irani A N., Malhi H, Slehria S et al. Correction of liver disease following transplantation of normal rat hepatocytes into Long-Evans Cinnamon rats modeling Wilson's disease. Mol Ther 2001 3 3 302-309 (Pubitemid 32514645)
89. Malhi H, Irani A N., Volenberg I, Schilsky M L., Gupta S. Early cell transplantation in LEC rats modeling Wilson's disease eliminates hepatic copper with reversal of liver disease. Gastroenterology 2002 122 2 438-447 (Pubitemid 34116995)
90. Fox A N., Schilsky M. Once daily trientine for maintenance therapy of Wilson disease. Am J Gastroenterol 2008 103 2 494-495 (Pubitemid 351248740)
91. Nazer H, Ede R J., Mowat A P., Williams R. Wilson's disease: clinical presentation and use of prognostic index. Gut 1986 27 11 1377-1381 (Pubitemid 17175689)
92. Lingam S, Wilson J, Nazer H, Mowat A P. Neurological abnormalities in Wilson's disease are reversible. Neuropediatrics 1987 18 1 11-12 (Pubitemid 17079938)
93. Brewer G J., Terry C A., Aisen A M., Hill G M. Worsening of neurologic syndrome in patients with Wilson's disease with initial penicillamine therapy. Arch Neurol 1987 44 5 490-493 (Pubitemid 17061929)
94. Glass J D., Reich S G., DeLong M R. Wilson's disease. Development of neurological disease after beginning penicillamine therapy. Arch Neurol 1990 47 5 595-596 (Pubitemid 20155851)
95. Brewer G J., Askari F, Lorincz M T. et al. Treatment of Wilson disease with ammonium tetrathiomolybdate: IV. Comparison of tetrathiomolybdate and trientine in a double-blind study of treatment of the neurologic presentation of Wilson disease. Arch Neurol 2006 63 4 521-527
96. Arnon R, Annunziato R, Schilsky M et al. Liver transplantation for children with Wilson disease: comparison of outcomes between children and adults. Clin Transplant 2011 25 1 E52-E60
97. Medici V, Mirante V G., Fassati L R. et al, Monotematica AISF 2000 OLT Study Group. Liver transplantation for Wilson's disease: the burden of neurological and psychiatric disorders. Liver Transpl 2005 11 9 1056-1063 (Pubitemid 41341754)
98. Sevmis S, Karakayali H, Aliosmanoglu I et al. Liver transplantation for Wilson's disease. Transplant Proc 2008 40 1 228-230 (Pubitemid 351186608)